Interní Med. 2013; 15(3-4): 133-136

Experiences with nutritional support in cancer patients treated with chemotherapy, radiotherapy and surgery -

MUDr.Milada Zemanová, Ph.D.
Onkologická klinika 1. LF UK a VFN, Praha

esophageal cancer case report

The prognosis of esophageal cancer is unfavourable even in patients in the operable stage of the disease. In the well-conditioned patients

the pre-operative concurrent chemoradiotherapy followed by resection is considered a treatment standard, which increases the

probability of two-year survival by 13 percent in compare to surgery alone. This multimodal approach belongs to most challenging

ones in oncology, with operative mortality rate being about 10 percent. The risk of surgery complications including death is greater in

patients with unfavourable nutritional status with body weight decrease higher than 10 percent, while about 50 percent of esophageal

cancer patients belong to this category. Perioperative nutritional support of these patients is unambiguously beneficial. The case-report

presented here demonstrates succesfull course of multimodal treatment of squamous cell esophageal cancer using pre-operative

concurrent chemoradiotherapy followed by resection accompanied by three-field lymphadenectomy (including cervical dissection).

Despite of several unfavourable prognostic indicators (serious premorbid body weight decrease, necessity of nasojejunal tube insertion

because of temporary severe dysphagia, peroperative lymph-node positivity) the patient is in clinical remission more than two years

after the start of treatment. We suppose that systematic and intensive nutritional support could in this case favourably influence the

course of the disease.

Keywords: esophageal cancer, concurrent chemoradiotherapy, nutritional support

Published: March 20, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zemanová M. Experiences with nutritional support in cancer patients treated with chemotherapy, radiotherapy and surgery -. Interní Med. 2013;15(3-4):133-136.
Download citation

References

  1. Pazdro A. Chirurgie jícnu in Pafko et al: Causae mortis v chirurgii II - monografie, Grada, 2004: 90-95.
  2. Iyer R, Wilkinson N, demmy T, et al. Controversies in the multimodality management of locally advanced esophageal cancer: Evidence-based review of Sumery alone and combined-modality therapy. Ann Surg Oncol 2004; 11: 665-673. Go to original source... Go to PubMed...
  3. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-234. Go to original source... Go to PubMed...
  4. Malhaire JP, Labat JP, Lozach P, et al. Preoperative concomitant radiochemotherapy in squamous cell carcinoma of the esophagus: results of a study of 56 patients. Int J radiat Oncol Biol Phys 1996; 34(2), 429-437. Go to original source... Go to PubMed...
  5. Deans Ch, Wigmore S. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 2005; 8, 265-269. Go to original source... Go to PubMed...
  6. Gallus S, LaVecchia C, Levi F, et al. Leanness and squamous cell oesophageal cancer. Annals of Oncol 2001; 12(7), 975-979. Go to original source... Go to PubMed...
  7. Hennequin C, Gayet B, Sauvanet A, et al. Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Rad Oncol Biol Phys 2001; 49(3), 657-664. Go to original source... Go to PubMed...
  8. Zatloukal P, Petruzelka L, Zemanova M, et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 2004; 46(1): 87-98. Go to original source... Go to PubMed...
  9. Bozzetti F. Nutrition and gastrointestinal cancer Curr Opin Clin Nutr Metab Care 2001; 4: 541-546. Go to original source... Go to PubMed...
  10. Zemanova M, Petruzelka L, Pazdro A, et al. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up. Dis Esophagus, 2010; 23(2): 160-167. Epub 2009 Jun 9. Go to original source... Go to PubMed...
  11. Zemanova M, Novak F, Vítek P, et al. Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors. Journal of BUON 2012; 17: 310-316. Go to PubMed...
  12. Knyrim K, Wagner H, Bethge N, et al. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 78: 1302-1307. Go to original source... Go to PubMed...
  13. Di Fiore F, Lacleire S, Pop D, et al. Baseline nutritional status is predictive of response to treatment and survival in patient treated by definitive chemoradiotherapy for locally advanced esophageal cancer. Am J Gastroenterol 2007; 102: 2557-2563. Go to original source... Go to PubMed...
  14. O'Brien M, Bonomi P, Langer C, et al. Analysis of prognostic factors in chemo-na?ve patients with advanced NSCLC and poor performance status (PS): Cox regression analysis of two phase III trials. Journal of Clinical Oncology.2006, ASCO Annual Meeting Proceedings Part I. 2006; 24 (June 20 Supplement 18S): 7113. Go to original source...
  15. Andreyev HJN, Norman AR, Oates J, et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Europ J Cancer 1998; 34(4): 503-509. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.